Advertisement

Search Results

Advertisement



Your search for ,Say matches 1419 pages

Showing 1401 - 1419


colorectal cancer
issues in oncology

Report Shows More Screening Has Led to a 30% Drop in Colon Cancer Rates

Findings from a report by Siegel et al of the American Cancer Society (ACS) show that the rate at which people are diagnosed with colorectal cancer in the United States has dropped by 30% in the last 10 years among people aged 50 years and older. The researchers say the decline in incidence is due...

colorectal cancer

Alternate VEGF Ligands Associated With Bevacizumab Resistance in Metastatic Colorectal Cancer

Results from a University of Colorado Cancer Center study indicated that bevacizumab (Avastin) resistance in patients with colorectal cancer may be due to increases in growth factors other than the targeted VEGF-A. The study, led by Christopher Lieu, MD, and published in the journal PLoS One,...

lung cancer

Investigational EGFR Inhibitor May Hold Promise for Some Patients With Treatment-Resistant NSCLC

Approximately 50% of non–small cell lung cancer (NSCLC) patients who develop resistance to inhibitors of the epidermal growth factor receptor (EGFR) have acquired a second mutation, T790M, which no current EGFR inhibitors target. This may change if the AstraZeneca investigational compound...

breast cancer
issues in oncology

Breast Cancer Treatment in 10 Years: George Sledge, MD, Offers His Predictions

In a keynote lecture during the 2013 Breast Cancer Symposium breast cancer expert and ASCO Past President George Sledge, MD, offered five predictions for the future of the medical management of breast cancer. Dr. Sledge is now Chief of Oncology at Stanford University School of Medicine, Palo Alto,...

skin cancer

Enhanced Treatment, Surveillance Needed for Certain Melanoma Patients to Prevent Secondary Cancers, Researchers Say

Researchers at Moffitt Cancer Center in Tampa, Florida, suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become...

breast cancer
issues in oncology

Multicenter Trial Finds BI-RADS 3 Breast Lesions Have Low Cancer Rate

Based on data from a multisite imaging trial involving more than 2,600 women, researchers say breast lesions categorized as “probably benign” on supplemental screening ultrasound could be reevaluated with imaging in 12 months, reducing patient anxiety, follow-up exams, and unnecessary...

solid tumors

Whole-Genome Sequencing Reveals Mutation Signature in Aristolochic Acid–Associated Upper Urinary Tract Cancer

Genomic sequencing experts at Johns Hopkins partnered with pharmacologists at Stony Brook University to reveal a striking mutational signature of upper urinary tract cancers caused by aristolochic acid, a plant compound contained in herbal remedies used for thousands of years to treat a variety of...

pancreatic cancer

Researchers Identify Origin of Inflammation-Driven Pancreatic Cancer

Researchers at Mayo Clinic in Florida have revealed the process by which pancreatitis—chronic inflammation of the pancreas—morphs into pancreatic cancer. They say their findings point to ways to identify pancreatitis patients at risk of pancreatic cancer and to potential drug therapies...

Critical Pathway in Cell Cycle May Lead to Cancer Development

A team of scientists at the Salk Institute for Biological Studies has identified why disruption of a vital pathway in cell cycle control leads to the proliferation of cancer cells. Their findings on telomeres, published today in Molecular Cell, suggest a potential target for preventive measures...

myelodysplastic syndromes

Targeting Errant Immune System Enzyme Kills Myelodysplastic Cells

Scientists have successfully targeted a malfunctioning immune system enzyme to kill diseased cells from patients with myelodysplastic syndrome (MDS), a precursor to acute myeloid leukemia (AML). Reporting their results in Cancer Cell, researchers say their successful laboratory tests in human MDS...

health-care policy

ASCO and Other Cancer Groups Ask for Guidance on Protecting Patient Access to Clinical Trials

A jointly signed letter by ASCO and more than 50 other cancer and health-care organizations to the Secretary of Health and Human Services (HHS) Kathleen Sebelius and Acting Secretary of the Department of Labor (DOL) Seth D. Harris asks that they provide clear federal regulations and guidance on...

issues in oncology

New Study Finds AICR Recommendations Cut Breast Cancer Risk

Postmenopausal women who follow at least five Recommendations for Cancer Prevention from the American Institute for Cancer Research (AICR) cut their risk of developing breast cancer by more than half, compared to those who meet none, suggests a new study that adds to previous research showing...

breast cancer

Developmental Protein Plays Role in Spread of Cancer

A protein used by embryo cells during early development, and recently found in many different types of cancer, may serve as a switch regulating metastasis, according to researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center. The findings were ...

issues in oncology

ASCO 2013: Most U.S. Oncologists Report High Career Satisfaction, but Many Suffer Symptoms of Burnout

Although a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, according to a Mayo Clinic–led study released during the ASCO 2013 Annual Meeting (Abstract 6533). “Oncology can be a tremendously rewarding...

gynecologic cancers

Study: Gold Nanoparticles Can Help Fight Ovarian Cancer

Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why and determined how to make the nanoparticles effective against ovarian cancer cells. The discovery is detailed in the current...

breast cancer

New Agent Might Control Breast Cancer Growth and Spread

A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that an unusual experimental drug can reduce breast cancer aggressiveness, reverse resistance to...

prostate cancer

Tougher Criteria May Be Needed for African Americans Considering Prostate Cancer Surveillance

New research from The Cancer Institute of New Jersey suggests that more stringent criteria may be needed for African American men with prostate cancer when considering active surveillance of the disease.  The findings, published in the latest online version of Urology found that the prevalence ...

colorectal cancer
issues in oncology

Colonoscopy Screening Reduces Risk of Advanced Colorectal Cancer, Study Shows

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that colonoscopy screening substantially reduces an average-risk adult’s likelihood of being diagnosed with advanced colorectal...

breast cancer

Breast Cancer Patients’ Fear of Developing Lymphedema Far Exceeds Risk

Women who have had the lymph nodes under their arm surgically removed during breast cancer treatment are warned to avoid certain practices that can cause lymphedema. Now, a new study published in the March issue of the Journal of the American College of Surgeons suggests that the vast majority of...

Advertisement

Advertisement




Advertisement